Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma

被引：7

作者：

Rodgers, Thomas D. ^{[1
]}

Baran, Andrea ^{[1
]}

Reagan, Patrick M. ^{[1
]}

Casulo, Carla ^{[1
]}

Zent, Clive ^{[1
]}

Evans, Andrew ^{[2
]}

Burack, Richard ^{[2
]}

Williams, AnnaLynn M. ^{[1
]}

Friedberg, Jonathan W. ^{[1
]}

Barr, Paul M. ^{[1
]}

机构：

[1] Univ Rochester, Wilmot Canc Inst, Rochester, NY 14627 USA

[2] Univ Rochester, Dept Pathol, Rochester, NY 14627 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 188卷 / 04期

关键词：

NON-HODGKIN-LYMPHOMA; SINGLE-AGENT LENALIDOMIDE; RITUXIMAB;

D O I：

10.1111/bjh.16302

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E33 / +

页数：4

共 14 条

[1] Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Chapuy, Bjoern
Stewart, Chip
Dunford, Andrew J.
Kim, Jaegil
Kamburov, Atanas
Redd, Robert A.
Lawrence, Mike S.
Roemer, Margaretha G. M.
Li, Amy J.
Ziepert, Marita
Staiger, Annette M.
Wala, Jeremiah A.
Ducar, Matthew D.
Leshchiner, Ignaty
Rheinbay, Ester
Taylor-Weiner, Amaro
Coughlin, Caroline A.
Hess, Julian M.
Pedamallu, Chandra S.
Livitz, Dimitri
Rosebrock, Daniel
Rosenberg, Mara
Tracy, Adam A.
Horn, Heike
van Hummelen, Paul
Feldman, Andrew L.
Link, Brian K.
Novak, Anne J.
Cerhan, James R.
Habermann, Thomas M.
Siebert, Reiner
Rosenwald, Andreas
Thorner, Aaron R.
Meyerson, Matthew L.
Golub, Todd R.
Beroukhim, Rameen
Wulf, Gerald G.
Ott, German
Rodig, Scott J.
Monti, Stefano
Neuberg, Donna S.
Loeffler, Markus
Pfreundschuh, Michael
Truemper, Lorenz
Getz, Gad
Shipp, Margaret A.
[J]. NATURE MEDICINE, 2018, 24 (05) : 679 - +
[2] Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Cheson, Bruce D.
Fisher, Richard I.
Barrington, Sally F.
Cavalli, Franco
Schwartz, Lawrence H.
Zucca, Emanuele
Lister, T. Andrew
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 3059 - +
[3] Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
Crump, Michael
Neelapu, Sattva S.
Farooq, Umar
Van den Neste, Eric
Kuruvilla, John
Westin, Jason
Link, Brian K.
Hay, Annette
Cerhan, James R.
Zhu, Liting
Boussetta, Sami
Feng, Lei
Maurer, Matthew J.
Navale, Lynn
Wiezorek, Jeff
Go, William Y.
Gisselbrecht, Christian
[J]. BLOOD, 2017, 130 (16) : 1800 - 1808
[4] A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Czuczman, Myron S.
Trneny, Marek
Davies, Andrew
Rule, Simon
Linton, Kim M.
Wagner-Johnston, Nina
Gascoyne, Randy D.
Slack, Graham W.
Brousset, Pierre
Eberhard, David A.
Hernandez-Ilizaliturri, Francisco J.
Salles, Gilles
Witzig, Thomas E.
Zinzani, Pier Luigi
Wright, George W.
Staudt, Louis M.
Yang, Yandan
Williams, P. Mickey
Lih, Chih-Jian
Russo, Jacqueline
Thakurta, Anjan
Hagner, Patrick
Fustier, Pierre
Song, Dale
Lewis, Ian D.
[J]. CLINICAL CANCER RESEARCH, 2017, 23 (15) : 4127 - 4137
[5] The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin
Czuczman, Myron S.
Vose, Julie M.
Witzig, Thomas E.
Zinzani, Pier L.
Buckstein, Rena
Polikoff, Jonathan
Li, Ju
Pietronigro, Dennis
Ervin-Haynes, Annetti
Reeder, Craig B.
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (04) : 477 - 481
[6] Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma
Gribben, John G.
Fowler, Nathan
Morschhauser, Franck
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) : 2803 - U127
[7] Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
Hans, CP
Weisenburger, DD
Greiner, TC
Gascoyne, RD
Delabie, J
Ott, G
Müller-Hermelink, HK
Campo, E
Braziel, RM
Jaffe, ES
Pan, ZG
Farinha, P
Smith, LM
Falini, B
Banham, AH
Rosenwald, A
Staudt, LM
Connors, JM
Armitage, JO
Chan, WC
[J]. BLOOD, 2004, 103 (01) : 275 - 282
[8] AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma
Leonard, John P.
Trneny, Marek
Izutsu, Koji
Fowler, Nathan H.
Hong, Xiaonan
Zhu, Jun
Zhang, Huilai
Offner, Fritz
Scheliga, Adriana
Nowakowski, Grzegorz S.
Pinto, Antonio
Re, Francesca
Fogliatto, Laura Maria
Scheinberg, Phillip
Flinn, Ian W.
Moreira, Claudia
Cabecadas, Jose
Liu, David
Kalambakas, Stacey
Fustier, Pierre
Wu, Chengqing
Gribben, John G.
Calaminici, Maria
Copie-Bergman, Christiane
Lopez-Guillermo, Armando
O'Connor, Owen
Williams, Michael
Suciu, Stefan
Levine, Benjamin
Kern, Julie
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (14) : 1188 - +
[9] Nowakowski GS, 2019, Hematol Oncol, V37, P37
[10] Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
Schmitz, R.
Wright, G. W.
Huang, D. W.
Johnson, C. A.
Phelan, J. D.
Wang, J. Q.
Roulland, S.
Kasbekar, M.
Young, R. M.
Shaffer, A. L.
Hodson, D. J.
Xiao, W.
Yu, X.
Yang, Y.
Zhao, H.
Xu, W.
Liu, X.
Zhou, B.
Du, W.
Chan, W. C.
Jaffe, E. S.
Gascoyne, R. D.
Connors, J. M.
Campo, E.
Lopez-Guillermo, A.
Rosenwald, A.
Ott, G.
Delabie, J.
Rimsza, L. M.
Wei, K. Tay Kuang
Zelenetz, A. D.
Leonard, J. P.
Bartlett, N. L.
Tran, B.
Shetty, J.
Zhao, Y.
Soppet, D. R.
Pittaluga, S.
Wilson, W. H.
Staudt, L. M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (15) : 1396 - 1407

← 1 2 →